Hunan Tat Ka Wai Hong Pharmaceutical Co., Ltd.

National AAAA-level pharmaceutical logistics enterprise, Hunan Province AAA-level credit enterprise, Hunan Province integrity management demonstration enterprise, Hunan Province pharmaceutical reserve enterprise, Hunan Province public health emergency supplies storage enterprise, Changsha’s self-created well-known brand trade circulation enterprise, and one of the top 100 in the country Pharmaceutical business enterprise.

The company specializes in the operation of high-end and high-end drugs such as anti-tumor drugs, transplant drugs, and anti-viral drugs. It has cooperated with Boehringer Ingelheim, Bayer, Eli Lilly, Pfizer, Bristol-Myers Squibb, Jiangsu Hengrui, Jiangsu Hansoh, Jiangsu Aosaikang, Jiangsu Zhengda Tianqing, Shanghai CITIC Guojian, Livzon Pharmaceutical, and Jiangsu Suzhong have established stable cooperative relationships with more than 1,000 well-known domestic and foreign pharmaceutical companies, and have become the only or main agents in Hunan.

The company mainly focuses on the pure sales and distribution business of hospitals, and has established a three-dimensional sales network covering the entire province, including 100% coverage of third-level and above medical institutions in the province, and 80% coverage of second-level medical institutions. The sales channels in the terminal market currently cover private enterprises. There are more than 3,000 third-end market customers including hospitals, clinics, community health centers, township health centers, village clinics, chain and independent pharmacies. Sales terminals open up the last mile from counties and cities to villages and towns.